BioSpace News Archive

Deals

PerkinElmer Board Declares Quarterly Dividend payable on February 7, 2020

The Board of Directors of PerkinElmer, Inc., declared a regular quarterly dividend of $0.07 per share of common stock on October 24, 2019.

October 24, 2019
·
1 min read
Business

Anika Reports Third Quarter 2019 Financial Results

Total Revenue Increases 11% and Net Income Increases 21% Year-over-Year

October 24, 2019
·
12 min read
Drug Development

Mustang Bio Announces Dosing of First Participant in Phase 1 Clinical Trial of MB-108 (Oncolytic Virus C134) to Treat GlioblastomaFirst dose occurred in trial currently underway at the University of Alabama at Birmingham

Mustang Bio, Inc. announced that the first participant has been dosed in a Phase 1 clinical trial to determine the safety and efficacy of MB-108, an attenuated herpes simplex virus type 1, in recurrent glioblastoma multiforme.

October 24, 2019
·
4 min read
BioMidwest

Predictive Oncology: Helomics to present initial findings from its analysis of UK 100,000 Genomes Project data towards its goal of building AI-driven predictive models of ovarian cancer

Predictive Oncology announces that Helomics CTO Dr. Mark Collins will speak during the scientific session of the conference, and will participate in an invite-only session on the expansion of the UK100K GP to 5 Million genomes.

October 24, 2019
·
6 min read
Deals

AZTherapies Strengthens Neuroinflammation-Targeted Pipeline Through Acquisition of Smith Therapeutics

AZTherapies, Inc., a biopharmaceutical company developing therapeutics to extend brain health, today announced the acquisition of Smith Therapeutics, a private biopharmaceutical company with a shared goal of targeting neuroinflammation to treat neurodegenerative disease.

October 24, 2019
·
3 min read
BioMidwest

AbbVie to Present at the Wolfe Research Inaugural Healthcare Conference

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Wolfe Research Inaugural Healthcare Conference on Wednesday, November 6. Richard A. Gonzalez, chairman and chief executive officer, will present at 8:30 a.m. Central time.

October 24, 2019
·
2 min read
BioCapital

AmerisourceBergen’s ThinkLive Summit Looks to the Future of Pharmaceutical Care

Nearly 400 pharmaceutical manufacturers join the healthcare solutions leader for two-day event focused on innovation and patient access

October 24, 2019
·
4 min read
Job Trends

Aspen Laser Receives Award from Global Health & Pharma

Recognized as “Best Laser Therapy Provider” in the 2019 International Life Sciences Awards category

October 24, 2019
·
3 min read
Deals

CEL-SCI Corporation Issues Letter to Shareholders - Oct. 24, 2019

We at CEL-SCI have been believers in the value of immunotherapy for treating cancer for decades before others recognized it’s potential.

October 24, 2019
·
11 min read
Business

MC10 and University of Vermont Announce Partnership to Advance Understanding of Gait Abnormalities in Movement Disorders

MC10, Inc., the developer of BioStamp nPoint, an end-to-end system for physiological data collection and analytics, announced today a collaboration with the University of Vermont, a leading academic research institution.

October 24, 2019
·
3 min read